nodes	percent_of_prediction	percent_of_DWPC	metapath
Droxidopa—Isoetarine—asthma	0.206	0.569	CrCtD
Droxidopa—Isoprenaline—asthma	0.156	0.431	CrCtD
Droxidopa—ADRB2—asthma	0.0829	1	CbGaD
Droxidopa—ADRB3—Isoprenaline—asthma	0.0219	0.096	CbGbCtD
Droxidopa—ADRB2—Orciprenaline—asthma	0.0216	0.0946	CbGbCtD
Droxidopa—ADRB2—Isoetarine—asthma	0.0164	0.0717	CbGbCtD
Droxidopa—ADRB2—Pirbuterol—asthma	0.0164	0.0717	CbGbCtD
Droxidopa—ADRB2—Terbutaline—asthma	0.0164	0.0717	CbGbCtD
Droxidopa—ADRB1—Isoetarine—asthma	0.0161	0.0706	CbGbCtD
Droxidopa—ADRB1—Pirbuterol—asthma	0.0161	0.0706	CbGbCtD
Droxidopa—Isoetarine—Orciprenaline—asthma	0.0156	0.0606	CrCrCtD
Droxidopa—Dopamine—Isoetarine—asthma	0.0122	0.0472	CrCrCtD
Droxidopa—Norepinephrine—Isoetarine—asthma	0.0122	0.0472	CrCrCtD
Droxidopa—Methyldopa—Isoetarine—asthma	0.0122	0.0472	CrCrCtD
Droxidopa—Epinephrine—Pirbuterol—asthma	0.0117	0.0455	CrCrCtD
Droxidopa—Levonordefrin—Isoetarine—asthma	0.0114	0.0443	CrCrCtD
Droxidopa—ADRB2—Indacaterol—asthma	0.0113	0.0497	CbGbCtD
Droxidopa—ADRB1—Indacaterol—asthma	0.0112	0.0489	CbGbCtD
Droxidopa—Epinephrine—Orciprenaline—asthma	0.011	0.0428	CrCrCtD
Droxidopa—Carbidopa—Isoprenaline—asthma	0.0107	0.0414	CrCrCtD
Droxidopa—ADRB2—Salmeterol—asthma	0.0105	0.0462	CbGbCtD
Droxidopa—ADRB2—Salbutamol—asthma	0.0105	0.0462	CbGbCtD
Droxidopa—ADRB1—Salbutamol—asthma	0.0104	0.0455	CbGbCtD
Droxidopa—Isoetarine—Isoprenaline—asthma	0.00988	0.0384	CrCrCtD
Droxidopa—Epinephrine—Terbutaline—asthma	0.00956	0.0371	CrCrCtD
Droxidopa—Methyldopa—Isoprenaline—asthma	0.00922	0.0358	CrCrCtD
Droxidopa—Norepinephrine—Isoprenaline—asthma	0.00922	0.0358	CrCrCtD
Droxidopa—Dopamine—Isoprenaline—asthma	0.00922	0.0358	CrCrCtD
Droxidopa—Epinephrine—Isoetarine—asthma	0.0092	0.0357	CrCrCtD
Droxidopa—Isoprenaline—Orciprenaline—asthma	0.00897	0.0348	CrCrCtD
Droxidopa—Isoetarine—Salbutamol—asthma	0.00897	0.0348	CrCrCtD
Droxidopa—ADRB2—Isoprenaline—asthma	0.00896	0.0393	CbGbCtD
Droxidopa—ADRB1—Isoprenaline—asthma	0.00883	0.0387	CbGbCtD
Droxidopa—Levonordefrin—Isoprenaline—asthma	0.00865	0.0336	CrCrCtD
Droxidopa—Norepinephrine—Salbutamol—asthma	0.00837	0.0325	CrCrCtD
Droxidopa—L-DOPA—Isoetarine—asthma	0.00808	0.0314	CrCrCtD
Droxidopa—ADRB2—Formoterol—asthma	0.00799	0.035	CbGbCtD
Droxidopa—ADRB2—Arformoterol—asthma	0.00799	0.035	CbGbCtD
Droxidopa—ADRB1—Arformoterol—asthma	0.00787	0.0345	CbGbCtD
Droxidopa—ADRB1—Formoterol—asthma	0.00787	0.0345	CbGbCtD
Droxidopa—Levonordefrin—Salbutamol—asthma	0.00785	0.0305	CrCrCtD
Droxidopa—Isoprenaline—Terbutaline—asthma	0.00778	0.0302	CrCrCtD
Droxidopa—Isoprenaline—Isoetarine—asthma	0.00749	0.0291	CrCrCtD
Droxidopa—Epinephrine—Isoprenaline—asthma	0.00698	0.0271	CrCrCtD
Droxidopa—Isoprenaline—Arformoterol—asthma	0.0068	0.0264	CrCrCtD
Droxidopa—Isoprenaline—Formoterol—asthma	0.0068	0.0264	CrCrCtD
Droxidopa—Epinephrine—Salbutamol—asthma	0.00633	0.0246	CrCrCtD
Droxidopa—L-DOPA—Isoprenaline—asthma	0.00613	0.0238	CrCrCtD
Droxidopa—Isoprenaline—Salbutamol—asthma	0.00515	0.02	CrCrCtD
Droxidopa—Myocardial ischaemia—Indacaterol—asthma	0.000821	0.0275	CcSEcCtD
Droxidopa—Blood pressure increased—Fluticasone furoate—asthma	0.000613	0.0205	CcSEcCtD
Droxidopa—SLC6A2—autonomic nervous system—asthma	0.000461	0.166	CbGeAlD
Droxidopa—Arrhythmia—Isoprenaline—asthma	0.00038	0.0127	CcSEcCtD
Droxidopa—Urinary tract infection—Zileuton—asthma	0.000364	0.0122	CcSEcCtD
Droxidopa—Myocardial ischaemia—Salbutamol—asthma	0.000357	0.0119	CcSEcCtD
Droxidopa—Hypertension—Isoprenaline—asthma	0.000319	0.0107	CcSEcCtD
Droxidopa—Shock—Dyphylline—asthma	0.000306	0.0102	CcSEcCtD
Droxidopa—Blood pressure increased—Arformoterol—asthma	0.000304	0.0102	CcSEcCtD
Droxidopa—Blood pressure increased—Formoterol—asthma	0.000304	0.0102	CcSEcCtD
Droxidopa—Arrhythmia—Orciprenaline—asthma	0.000294	0.00984	CcSEcCtD
Droxidopa—Aminosalicylic Acid—ALOX5—asthma	0.000289	0.27	CrCbGaD
Droxidopa—Blood pressure increased—Salbutamol—asthma	0.000287	0.0096	CcSEcCtD
Droxidopa—Urinary tract infection—Ciclesonide—asthma	0.000285	0.00955	CcSEcCtD
Droxidopa—Syncope—Ketotifen—asthma	0.000271	0.00908	CcSEcCtD
Droxidopa—Loss of consciousness—Ketotifen—asthma	0.000266	0.0089	CcSEcCtD
Droxidopa—Hypertension—Ketotifen—asthma	0.000261	0.00874	CcSEcCtD
Droxidopa—Syncope—Orciprenaline—asthma	0.000257	0.0086	CcSEcCtD
Droxidopa—Loss of consciousness—Orciprenaline—asthma	0.000252	0.00843	CcSEcCtD
Droxidopa—Syncope—Pirbuterol—asthma	0.00025	0.00836	CcSEcCtD
Droxidopa—DDC—respiratory system—asthma	0.000249	0.0896	CbGeAlD
Droxidopa—Hypertension—Orciprenaline—asthma	0.000247	0.00828	CcSEcCtD
Droxidopa—Arrhythmia—Theophylline—asthma	0.000246	0.00823	CcSEcCtD
Droxidopa—Loss of consciousness—Pirbuterol—asthma	0.000245	0.0082	CcSEcCtD
Droxidopa—Cardiac failure congestive—Formoterol—asthma	0.000243	0.00814	CcSEcCtD
Droxidopa—Cardiac failure congestive—Arformoterol—asthma	0.000243	0.00814	CcSEcCtD
Droxidopa—Shock—Ketotifen—asthma	0.000243	0.00813	CcSEcCtD
Droxidopa—Urinary tract infection—Ipratropium bromide—asthma	0.000237	0.00792	CcSEcCtD
Droxidopa—Shock—Orciprenaline—asthma	0.00023	0.0077	CcSEcCtD
Droxidopa—Confusional state—Pirbuterol—asthma	0.000229	0.00767	CcSEcCtD
Droxidopa—Urinary tract infection—Salmeterol—asthma	0.000228	0.00765	CcSEcCtD
Droxidopa—Mesalazine—ALOX5—asthma	0.000227	0.212	CrCbGaD
Droxidopa—Shock—Pirbuterol—asthma	0.000224	0.00749	CcSEcCtD
Droxidopa—Urinary tract infection—Tiotropium—asthma	0.000205	0.00685	CcSEcCtD
Droxidopa—Dizziness—Isoprenaline—asthma	0.0002	0.00669	CcSEcCtD
Droxidopa—Hypertension—Ciclesonide—asthma	0.000198	0.00663	CcSEcCtD
Droxidopa—Feeling abnormal—Zileuton—asthma	0.000197	0.0066	CcSEcCtD
Droxidopa—Headache—Dyphylline—asthma	0.000195	0.00652	CcSEcCtD
Droxidopa—Shock—Theophylline—asthma	0.000192	0.00644	CcSEcCtD
Droxidopa—Dizziness—Terbutaline—asthma	0.000192	0.00643	CcSEcCtD
Droxidopa—Urinary tract infection—Flunisolide—asthma	0.00019	0.00635	CcSEcCtD
Droxidopa—Headache—Isoprenaline—asthma	0.000189	0.00634	CcSEcCtD
Droxidopa—Arrhythmia—Fluticasone Propionate—asthma	0.000189	0.00633	CcSEcCtD
Droxidopa—Arrhythmia—Salmeterol—asthma	0.000189	0.00631	CcSEcCtD
Droxidopa—Feeling abnormal—Pirbuterol—asthma	0.000187	0.00627	CcSEcCtD
Droxidopa—Nausea—Dyphylline—asthma	0.000185	0.00618	CcSEcCtD
Droxidopa—Headache—Terbutaline—asthma	0.000182	0.00609	CcSEcCtD
Droxidopa—Nausea—Isoprenaline—asthma	0.000179	0.00601	CcSEcCtD
Droxidopa—Arrhythmia—Aminophylline—asthma	0.000179	0.00599	CcSEcCtD
Droxidopa—Urinary tract infection—Mometasone—asthma	0.000176	0.00589	CcSEcCtD
Droxidopa—Nausea—Terbutaline—asthma	0.000172	0.00577	CcSEcCtD
Droxidopa—Feeling abnormal—Zafirlukast—asthma	0.000169	0.00567	CcSEcCtD
Droxidopa—Arrhythmia—Loratadine—asthma	0.000169	0.00566	CcSEcCtD
Droxidopa—Isoetarine—ADRB2—asthma	0.000169	0.158	CrCbGaD
Droxidopa—Arrhythmia—Tiotropium—asthma	0.000169	0.00565	CcSEcCtD
Droxidopa—Urinary tract infection—Formoterol—asthma	0.000165	0.00553	CcSEcCtD
Droxidopa—Urinary tract infection—Arformoterol—asthma	0.000165	0.00553	CcSEcCtD
Droxidopa—Hypertension—Ipratropium bromide—asthma	0.000164	0.0055	CcSEcCtD
Droxidopa—Dizziness—Ketotifen—asthma	0.000163	0.00547	CcSEcCtD
Droxidopa—ADRA1D—epithelium—asthma	0.00016	0.0578	CbGeAlD
Droxidopa—Hypertension—Fluticasone Propionate—asthma	0.000159	0.00532	CcSEcCtD
Droxidopa—Hypertension—Salmeterol—asthma	0.000159	0.00531	CcSEcCtD
Droxidopa—Dizziness—Zileuton—asthma	0.000158	0.00529	CcSEcCtD
Droxidopa—Urinary tract infection—Salbutamol—asthma	0.000156	0.00522	CcSEcCtD
Droxidopa—Dizziness—Indacaterol—asthma	0.000156	0.00521	CcSEcCtD
Droxidopa—Headache—Ketotifen—asthma	0.000155	0.00518	CcSEcCtD
Droxidopa—Dizziness—Orciprenaline—asthma	0.000155	0.00518	CcSEcCtD
Droxidopa—Dizziness—Nedocromil—asthma	0.000151	0.00507	CcSEcCtD
Droxidopa—Urinary tract infection—Budesonide—asthma	0.000151	0.00506	CcSEcCtD
Droxidopa—DDC—adrenal gland—asthma	0.000151	0.0543	CbGeAlD
Droxidopa—Dizziness—Pirbuterol—asthma	0.00015	0.00503	CcSEcCtD
Droxidopa—Headache—Zileuton—asthma	0.00015	0.00502	CcSEcCtD
Droxidopa—Syncope—Loratadine—asthma	0.000148	0.00495	CcSEcCtD
Droxidopa—Syncope—Tiotropium—asthma	0.000148	0.00494	CcSEcCtD
Droxidopa—Headache—Indacaterol—asthma	0.000148	0.00494	CcSEcCtD
Droxidopa—Nausea—Ketotifen—asthma	0.000147	0.00491	CcSEcCtD
Droxidopa—Headache—Orciprenaline—asthma	0.000146	0.0049	CcSEcCtD
Droxidopa—Loss of consciousness—Loratadine—asthma	0.000145	0.00485	CcSEcCtD
Droxidopa—Dizziness—Fluticasone furoate—asthma	0.000145	0.00484	CcSEcCtD
Droxidopa—Loss of consciousness—Tiotropium—asthma	0.000145	0.00484	CcSEcCtD
Droxidopa—Headache—Nedocromil—asthma	0.000143	0.0048	CcSEcCtD
Droxidopa—SLC16A10—epithelium—asthma	0.000143	0.0514	CbGeAlD
Droxidopa—Headache—Pirbuterol—asthma	0.000142	0.00477	CcSEcCtD
Droxidopa—Hypertension—Loratadine—asthma	0.000142	0.00477	CcSEcCtD
Droxidopa—Hypertension—Tiotropium—asthma	0.000142	0.00476	CcSEcCtD
Droxidopa—Nausea—Zileuton—asthma	0.000142	0.00476	CcSEcCtD
Droxidopa—Shock—Aminophylline—asthma	0.00014	0.00469	CcSEcCtD
Droxidopa—Feeling abnormal—Cromoglicic acid—asthma	0.00014	0.00469	CcSEcCtD
Droxidopa—Nausea—Indacaterol—asthma	0.00014	0.00468	CcSEcCtD
Droxidopa—Nausea—Orciprenaline—asthma	0.000139	0.00465	CcSEcCtD
Droxidopa—Headache—Fluticasone furoate—asthma	0.000137	0.00459	CcSEcCtD
Droxidopa—Syncope—Flunisolide—asthma	0.000137	0.00458	CcSEcCtD
Droxidopa—Arrhythmia—Formoterol—asthma	0.000136	0.00456	CcSEcCtD
Droxidopa—Arrhythmia—Arformoterol—asthma	0.000136	0.00456	CcSEcCtD
Droxidopa—Nausea—Nedocromil—asthma	0.000136	0.00455	CcSEcCtD
Droxidopa—Dizziness—Zafirlukast—asthma	0.000136	0.00455	CcSEcCtD
Droxidopa—Nausea—Pirbuterol—asthma	0.000135	0.00452	CcSEcCtD
Droxidopa—Loss of consciousness—Flunisolide—asthma	0.000134	0.00449	CcSEcCtD
Droxidopa—Shock—Loratadine—asthma	0.000132	0.00443	CcSEcCtD
Droxidopa—DDC—lung—asthma	0.000132	0.0476	CbGeAlD
Droxidopa—Shock—Tiotropium—asthma	0.000132	0.00442	CcSEcCtD
Droxidopa—Cardiac failure congestive—Prednisolone—asthma	0.000132	0.00441	CcSEcCtD
Droxidopa—Hypertension—Flunisolide—asthma	0.000132	0.00441	CcSEcCtD
Droxidopa—Nausea—Fluticasone furoate—asthma	0.00013	0.00435	CcSEcCtD
Droxidopa—Dizziness—Theophylline—asthma	0.000129	0.00433	CcSEcCtD
Droxidopa—Dizziness—Beclomethasone—asthma	0.000129	0.00433	CcSEcCtD
Droxidopa—Headache—Zafirlukast—asthma	0.000129	0.00431	CcSEcCtD
Droxidopa—Arrhythmia—Salbutamol—asthma	0.000129	0.00431	CcSEcCtD
Droxidopa—Cardiac failure congestive—Hydrocortisone—asthma	0.000129	0.00431	CcSEcCtD
Droxidopa—Feeling abnormal—Fluticasone Propionate—asthma	0.000124	0.00415	CcSEcCtD
Droxidopa—Dizziness—Ciclesonide—asthma	0.000124	0.00414	CcSEcCtD
Droxidopa—Feeling abnormal—Salmeterol—asthma	0.000124	0.00414	CcSEcCtD
Droxidopa—Headache—Theophylline—asthma	0.000122	0.0041	CcSEcCtD
Droxidopa—Headache—Beclomethasone—asthma	0.000122	0.0041	CcSEcCtD
Droxidopa—Shock—Flunisolide—asthma	0.000122	0.0041	CcSEcCtD
Droxidopa—Nausea—Zafirlukast—asthma	0.000122	0.00409	CcSEcCtD
Droxidopa—Cardiac failure congestive—Triamcinolone—asthma	0.000121	0.00405	CcSEcCtD
Droxidopa—Cardiac failure congestive—Methylprednisolone—asthma	0.000121	0.00405	CcSEcCtD
Droxidopa—SLC6A2—respiratory system—asthma	0.000119	0.0427	CbGeAlD
Droxidopa—Headache—Ciclesonide—asthma	0.000117	0.00392	CcSEcCtD
Droxidopa—Nausea—Beclomethasone—asthma	0.000116	0.00389	CcSEcCtD
Droxidopa—Nausea—Theophylline—asthma	0.000116	0.00389	CcSEcCtD
Droxidopa—ADRB1—bronchus—asthma	0.000115	0.0413	CbGeAlD
Droxidopa—Hypertension—Formoterol—asthma	0.000115	0.00384	CcSEcCtD
Droxidopa—Hypertension—Arformoterol—asthma	0.000115	0.00384	CcSEcCtD
Droxidopa—Syncope—Salbutamol—asthma	0.000112	0.00376	CcSEcCtD
Droxidopa—Dizziness—Cromoglicic acid—asthma	0.000112	0.00376	CcSEcCtD
Droxidopa—Nausea—Ciclesonide—asthma	0.000111	0.00372	CcSEcCtD
Droxidopa—Feeling abnormal—Loratadine—asthma	0.000111	0.00371	CcSEcCtD
Droxidopa—Loss of consciousness—Salbutamol—asthma	0.00011	0.00369	CcSEcCtD
Droxidopa—Cardiac failure congestive—Dexamethasone—asthma	0.00011	0.00368	CcSEcCtD
Droxidopa—Cardiac failure congestive—Betamethasone—asthma	0.00011	0.00368	CcSEcCtD
Droxidopa—Syncope—Budesonide—asthma	0.000109	0.00365	CcSEcCtD
Droxidopa—Hypertension—Salbutamol—asthma	0.000108	0.00362	CcSEcCtD
Droxidopa—ADRB1—cardiovascular system—asthma	0.000107	0.0385	CbGeAlD
Droxidopa—Loss of consciousness—Budesonide—asthma	0.000107	0.00357	CcSEcCtD
Droxidopa—Headache—Cromoglicic acid—asthma	0.000106	0.00357	CcSEcCtD
Droxidopa—Hypertension—Budesonide—asthma	0.000105	0.00351	CcSEcCtD
Droxidopa—Dizziness—Ipratropium bromide—asthma	0.000103	0.00344	CcSEcCtD
Droxidopa—Feeling abnormal—Flunisolide—asthma	0.000103	0.00343	CcSEcCtD
Droxidopa—Nausea—Cromoglicic acid—asthma	0.000101	0.00338	CcSEcCtD
Droxidopa—Shock—Salbutamol—asthma	0.000101	0.00337	CcSEcCtD
Droxidopa—Confusional state—Budesonide—asthma	9.99e-05	0.00335	CcSEcCtD
Droxidopa—Dizziness—Fluticasone Propionate—asthma	9.94e-05	0.00333	CcSEcCtD
Droxidopa—Dizziness—Salmeterol—asthma	9.91e-05	0.00332	CcSEcCtD
Droxidopa—Shock—Budesonide—asthma	9.75e-05	0.00327	CcSEcCtD
Droxidopa—Headache—Ipratropium bromide—asthma	9.73e-05	0.00326	CcSEcCtD
Droxidopa—Cardiac failure congestive—Prednisone—asthma	9.57e-05	0.0032	CcSEcCtD
Droxidopa—Dizziness—Aminophylline—asthma	9.42e-05	0.00315	CcSEcCtD
Droxidopa—Headache—Fluticasone Propionate—asthma	9.41e-05	0.00315	CcSEcCtD
Droxidopa—Headache—Salmeterol—asthma	9.39e-05	0.00315	CcSEcCtD
Droxidopa—Nausea—Ipratropium bromide—asthma	9.22e-05	0.00309	CcSEcCtD
Droxidopa—ADRA1A—epithelium—asthma	9.22e-05	0.0332	CbGeAlD
Droxidopa—SLC16A10—lung—asthma	9.07e-05	0.0326	CbGeAlD
Droxidopa—Feeling abnormal—Arformoterol—asthma	8.93e-05	0.00299	CcSEcCtD
Droxidopa—Feeling abnormal—Formoterol—asthma	8.93e-05	0.00299	CcSEcCtD
Droxidopa—Nausea—Fluticasone Propionate—asthma	8.93e-05	0.00299	CcSEcCtD
Droxidopa—Headache—Aminophylline—asthma	8.92e-05	0.00299	CcSEcCtD
Droxidopa—Nausea—Salmeterol—asthma	8.9e-05	0.00298	CcSEcCtD
Droxidopa—Dizziness—Loratadine—asthma	8.89e-05	0.00298	CcSEcCtD
Droxidopa—Dizziness—Tiotropium—asthma	8.88e-05	0.00297	CcSEcCtD
Droxidopa—ADRA2C—adrenal cortex—asthma	8.82e-05	0.0318	CbGeAlD
Droxidopa—ADRA2C—bronchus—asthma	8.65e-05	0.0311	CbGeAlD
Droxidopa—Nausea—Aminophylline—asthma	8.46e-05	0.00283	CcSEcCtD
Droxidopa—ADRA1A—cardiovascular system—asthma	8.45e-05	0.0304	CbGeAlD
Droxidopa—Feeling abnormal—Salbutamol—asthma	8.43e-05	0.00282	CcSEcCtD
Droxidopa—Headache—Loratadine—asthma	8.43e-05	0.00282	CcSEcCtD
Droxidopa—Headache—Tiotropium—asthma	8.41e-05	0.00282	CcSEcCtD
Droxidopa—Dizziness—Flunisolide—asthma	8.23e-05	0.00276	CcSEcCtD
Droxidopa—Feeling abnormal—Budesonide—asthma	8.17e-05	0.00273	CcSEcCtD
Droxidopa—Nausea—Loratadine—asthma	7.99e-05	0.00268	CcSEcCtD
Droxidopa—Nausea—Tiotropium—asthma	7.98e-05	0.00267	CcSEcCtD
Droxidopa—Headache—Flunisolide—asthma	7.8e-05	0.00261	CcSEcCtD
Droxidopa—ADRA2C—trachea—asthma	7.77e-05	0.028	CbGeAlD
Droxidopa—ADRB1—lung—asthma	7.41e-05	0.0267	CbGeAlD
Droxidopa—Nausea—Flunisolide—asthma	7.39e-05	0.00248	CcSEcCtD
Droxidopa—Arrhythmia—Prednisolone—asthma	7.38e-05	0.00247	CcSEcCtD
Droxidopa—Headache—Mometasone—asthma	7.23e-05	0.00242	CcSEcCtD
Droxidopa—Arrhythmia—Hydrocortisone—asthma	7.21e-05	0.00241	CcSEcCtD
Droxidopa—SLC6A2—adrenal gland—asthma	7.19e-05	0.0259	CbGeAlD
Droxidopa—Dizziness—Formoterol—asthma	7.17e-05	0.0024	CcSEcCtD
Droxidopa—Dizziness—Arformoterol—asthma	7.17e-05	0.0024	CcSEcCtD
Droxidopa—Dizziness—Montelukast—asthma	7.02e-05	0.00235	CcSEcCtD
Droxidopa—Isoprenaline—ADRB2—asthma	7.01e-05	0.0655	CrCbGaD
Droxidopa—Aminosalicylic Acid—PTGS2—asthma	6.99e-05	0.0653	CrCbGaD
Droxidopa—ADRA2A—bronchus—asthma	6.9e-05	0.0248	CbGeAlD
Droxidopa—Nausea—Mometasone—asthma	6.86e-05	0.0023	CcSEcCtD
Droxidopa—Headache—Arformoterol—asthma	6.79e-05	0.00227	CcSEcCtD
Droxidopa—Headache—Formoterol—asthma	6.79e-05	0.00227	CcSEcCtD
Droxidopa—Arrhythmia—Triamcinolone—asthma	6.79e-05	0.00227	CcSEcCtD
Droxidopa—Arrhythmia—Methylprednisolone—asthma	6.77e-05	0.00227	CcSEcCtD
Droxidopa—Dizziness—Salbutamol—asthma	6.77e-05	0.00227	CcSEcCtD
Droxidopa—ADRA1A—adrenal gland—asthma	6.68e-05	0.0241	CbGeAlD
Droxidopa—Headache—Montelukast—asthma	6.65e-05	0.00223	CcSEcCtD
Droxidopa—Epinephrine—TNF—asthma	6.65e-05	0.0621	CrCbGaD
Droxidopa—Dizziness—Budesonide—asthma	6.55e-05	0.00219	CcSEcCtD
Droxidopa—Norepinephrine—ADRB2—asthma	6.49e-05	0.0607	CrCbGaD
Droxidopa—Syncope—Prednisolone—asthma	6.45e-05	0.00216	CcSEcCtD
Droxidopa—Nausea—Arformoterol—asthma	6.44e-05	0.00216	CcSEcCtD
Droxidopa—Nausea—Formoterol—asthma	6.44e-05	0.00216	CcSEcCtD
Droxidopa—Headache—Salbutamol—asthma	6.41e-05	0.00215	CcSEcCtD
Droxidopa—ADRA2C—adrenal gland—asthma	6.37e-05	0.0229	CbGeAlD
Droxidopa—Loss of consciousness—Prednisolone—asthma	6.32e-05	0.00212	CcSEcCtD
Droxidopa—Nausea—Montelukast—asthma	6.3e-05	0.00211	CcSEcCtD
Droxidopa—SLC6A2—lung—asthma	6.3e-05	0.0227	CbGeAlD
Droxidopa—Syncope—Hydrocortisone—asthma	6.3e-05	0.00211	CcSEcCtD
Droxidopa—Headache—Budesonide—asthma	6.21e-05	0.00208	CcSEcCtD
Droxidopa—Hypertension—Prednisolone—asthma	6.21e-05	0.00208	CcSEcCtD
Droxidopa—ADRA2A—trachea—asthma	6.2e-05	0.0223	CbGeAlD
Droxidopa—Loss of consciousness—Hydrocortisone—asthma	6.17e-05	0.00207	CcSEcCtD
Droxidopa—Arrhythmia—Dexamethasone—asthma	6.16e-05	0.00206	CcSEcCtD
Droxidopa—Arrhythmia—Betamethasone—asthma	6.16e-05	0.00206	CcSEcCtD
Droxidopa—Nausea—Salbutamol—asthma	6.08e-05	0.00204	CcSEcCtD
Droxidopa—Hypertension—Hydrocortisone—asthma	6.06e-05	0.00203	CcSEcCtD
Droxidopa—Syncope—Triamcinolone—asthma	5.93e-05	0.00199	CcSEcCtD
Droxidopa—Syncope—Methylprednisolone—asthma	5.92e-05	0.00198	CcSEcCtD
Droxidopa—Epinephrine—ADRB2—asthma	5.89e-05	0.055	CrCbGaD
Droxidopa—Nausea—Budesonide—asthma	5.89e-05	0.00197	CcSEcCtD
Droxidopa—Loss of consciousness—Triamcinolone—asthma	5.81e-05	0.00195	CcSEcCtD
Droxidopa—Loss of consciousness—Methylprednisolone—asthma	5.8e-05	0.00194	CcSEcCtD
Droxidopa—Shock—Prednisolone—asthma	5.77e-05	0.00193	CcSEcCtD
Droxidopa—Hypertension—Triamcinolone—asthma	5.71e-05	0.00191	CcSEcCtD
Droxidopa—Hypertension—Methylprednisolone—asthma	5.7e-05	0.00191	CcSEcCtD
Droxidopa—Shock—Hydrocortisone—asthma	5.64e-05	0.00189	CcSEcCtD
Droxidopa—ADRA2C—lung—asthma	5.58e-05	0.0201	CbGeAlD
Droxidopa—Mesalazine—PTGS2—asthma	5.48e-05	0.0512	CrCbGaD
Droxidopa—Confusional state—Methylprednisolone—asthma	5.43e-05	0.00182	CcSEcCtD
Droxidopa—Syncope—Dexamethasone—asthma	5.38e-05	0.0018	CcSEcCtD
Droxidopa—Syncope—Betamethasone—asthma	5.38e-05	0.0018	CcSEcCtD
Droxidopa—Arrhythmia—Prednisone—asthma	5.36e-05	0.0018	CcSEcCtD
Droxidopa—Shock—Triamcinolone—asthma	5.31e-05	0.00178	CcSEcCtD
Droxidopa—Shock—Methylprednisolone—asthma	5.3e-05	0.00177	CcSEcCtD
Droxidopa—Loss of consciousness—Betamethasone—asthma	5.27e-05	0.00177	CcSEcCtD
Droxidopa—Loss of consciousness—Dexamethasone—asthma	5.27e-05	0.00177	CcSEcCtD
Droxidopa—Hypertension—Betamethasone—asthma	5.18e-05	0.00173	CcSEcCtD
Droxidopa—Hypertension—Dexamethasone—asthma	5.18e-05	0.00173	CcSEcCtD
Droxidopa—ADRA2A—adrenal gland—asthma	5.08e-05	0.0183	CbGeAlD
Droxidopa—Feeling abnormal—Prednisolone—asthma	4.84e-05	0.00162	CcSEcCtD
Droxidopa—Shock—Betamethasone—asthma	4.82e-05	0.00161	CcSEcCtD
Droxidopa—Shock—Dexamethasone—asthma	4.82e-05	0.00161	CcSEcCtD
Droxidopa—Feeling abnormal—Hydrocortisone—asthma	4.72e-05	0.00158	CcSEcCtD
Droxidopa—Syncope—Prednisone—asthma	4.69e-05	0.00157	CcSEcCtD
Droxidopa—Loss of consciousness—Prednisone—asthma	4.59e-05	0.00154	CcSEcCtD
Droxidopa—Hypertension—Prednisone—asthma	4.51e-05	0.00151	CcSEcCtD
Droxidopa—ADRA2A—lung—asthma	4.45e-05	0.016	CbGeAlD
Droxidopa—Feeling abnormal—Triamcinolone—asthma	4.45e-05	0.00149	CcSEcCtD
Droxidopa—Feeling abnormal—Methylprednisolone—asthma	4.44e-05	0.00149	CcSEcCtD
Droxidopa—Shock—Prednisone—asthma	4.2e-05	0.0014	CcSEcCtD
Droxidopa—Feeling abnormal—Dexamethasone—asthma	4.04e-05	0.00135	CcSEcCtD
Droxidopa—Feeling abnormal—Betamethasone—asthma	4.04e-05	0.00135	CcSEcCtD
Droxidopa—Dizziness—Prednisolone—asthma	3.88e-05	0.0013	CcSEcCtD
Droxidopa—Dizziness—Hydrocortisone—asthma	3.79e-05	0.00127	CcSEcCtD
Droxidopa—Headache—Prednisolone—asthma	3.68e-05	0.00123	CcSEcCtD
Droxidopa—Headache—Hydrocortisone—asthma	3.59e-05	0.0012	CcSEcCtD
Droxidopa—Dizziness—Triamcinolone—asthma	3.57e-05	0.0012	CcSEcCtD
Droxidopa—Dizziness—Methylprednisolone—asthma	3.56e-05	0.00119	CcSEcCtD
Droxidopa—Feeling abnormal—Prednisone—asthma	3.51e-05	0.00118	CcSEcCtD
Droxidopa—Nausea—Prednisolone—asthma	3.49e-05	0.00117	CcSEcCtD
Droxidopa—Nausea—Hydrocortisone—asthma	3.4e-05	0.00114	CcSEcCtD
Droxidopa—Headache—Triamcinolone—asthma	3.38e-05	0.00113	CcSEcCtD
Droxidopa—Headache—Methylprednisolone—asthma	3.37e-05	0.00113	CcSEcCtD
Droxidopa—Dizziness—Dexamethasone—asthma	3.24e-05	0.00108	CcSEcCtD
Droxidopa—Dizziness—Betamethasone—asthma	3.24e-05	0.00108	CcSEcCtD
Droxidopa—Nausea—Triamcinolone—asthma	3.21e-05	0.00107	CcSEcCtD
Droxidopa—Nausea—Methylprednisolone—asthma	3.2e-05	0.00107	CcSEcCtD
Droxidopa—Headache—Dexamethasone—asthma	3.07e-05	0.00103	CcSEcCtD
Droxidopa—Headache—Betamethasone—asthma	3.07e-05	0.00103	CcSEcCtD
Droxidopa—Nausea—Dexamethasone—asthma	2.91e-05	0.000974	CcSEcCtD
Droxidopa—Nausea—Betamethasone—asthma	2.91e-05	0.000974	CcSEcCtD
Droxidopa—Dizziness—Prednisone—asthma	2.82e-05	0.000944	CcSEcCtD
Droxidopa—Headache—Prednisone—asthma	2.67e-05	0.000895	CcSEcCtD
Droxidopa—Nausea—Prednisone—asthma	2.53e-05	0.000848	CcSEcCtD
Droxidopa—ADRA2A—Signaling Pathways—KNG1—asthma	1.65e-06	4.7e-05	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—IL2—asthma	1.65e-06	4.7e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—PPP2CA—asthma	1.65e-06	4.69e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CSF2—asthma	1.65e-06	4.69e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—POMC—asthma	1.64e-06	4.69e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PLA2G4A—asthma	1.64e-06	4.69e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—GSTM1—asthma	1.64e-06	4.69e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—AGTR1—asthma	1.64e-06	4.68e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CCR5—asthma	1.64e-06	4.67e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IL2RA—asthma	1.63e-06	4.64e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—SMAD3—asthma	1.63e-06	4.64e-05	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—IL2—asthma	1.62e-06	4.62e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CCR5—asthma	1.62e-06	4.61e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—IL2—asthma	1.62e-06	4.61e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—C3—asthma	1.62e-06	4.61e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IL2RA—asthma	1.61e-06	4.6e-05	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—IL2—asthma	1.61e-06	4.59e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—CCL2—asthma	1.61e-06	4.59e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—IL6R—asthma	1.6e-06	4.57e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—SMAD3—asthma	1.6e-06	4.57e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CXCL10—asthma	1.6e-06	4.57e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—IL2—asthma	1.6e-06	4.57e-05	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—IL6—asthma	1.6e-06	4.56e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—C3—asthma	1.6e-06	4.56e-05	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—RHOA—asthma	1.6e-06	4.55e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IL2RA—asthma	1.59e-06	4.54e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—ITPR1—asthma	1.58e-06	4.51e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—IL2—asthma	1.58e-06	4.51e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—C3—asthma	1.58e-06	4.51e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—PDGFB—asthma	1.57e-06	4.48e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—NTRK1—asthma	1.57e-06	4.48e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—CXCL8—asthma	1.57e-06	4.46e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—RHOA—asthma	1.56e-06	4.45e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—PPP2CA—asthma	1.56e-06	4.44e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—PDGFB—asthma	1.56e-06	4.44e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—FN1—asthma	1.56e-06	4.44e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—ADRB2—asthma	1.56e-06	4.44e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—CXCL8—asthma	1.54e-06	4.39e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—PDGFB—asthma	1.54e-06	4.39e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—PPP2CA—asthma	1.53e-06	4.37e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CCR5—asthma	1.53e-06	4.36e-05	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—MMP9—asthma	1.52e-06	4.34e-05	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—PTEN—asthma	1.51e-06	4.32e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PPP2CA—asthma	1.51e-06	4.31e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CD86—asthma	1.51e-06	4.3e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IL2RA—asthma	1.51e-06	4.3e-05	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—CXCL8—asthma	1.51e-06	4.3e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CCR5—asthma	1.51e-06	4.29e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—LEP—asthma	1.5e-06	4.29e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—IL2—asthma	1.5e-06	4.27e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—EDN1—asthma	1.5e-06	4.27e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—C3—asthma	1.5e-06	4.26e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—LEP—asthma	1.49e-06	4.25e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CCL5—asthma	1.48e-06	4.23e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IL2RA—asthma	1.48e-06	4.23e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—PLA2G4A—asthma	1.48e-06	4.22e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—IL2—asthma	1.47e-06	4.2e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—C3—asthma	1.47e-06	4.2e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—ITPR1—asthma	1.47e-06	4.2e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—LEP—asthma	1.47e-06	4.19e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CSF2—asthma	1.46e-06	4.17e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—PDGFB—asthma	1.46e-06	4.15e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—RHOA—asthma	1.45e-06	4.13e-05	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—IL2—asthma	1.44e-06	4.11e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—PDGFB—asthma	1.43e-06	4.08e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—POMC—asthma	1.43e-06	4.08e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—SMAD3—asthma	1.42e-06	4.06e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—FN1—asthma	1.42e-06	4.04e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—POMC—asthma	1.42e-06	4.04e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—FN1—asthma	1.41e-06	4.01e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CD86—asthma	1.4e-06	3.99e-05	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—CXCL8—asthma	1.4e-06	3.99e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—LEP—asthma	1.39e-06	3.97e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—EDN1—asthma	1.39e-06	3.96e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—FN1—asthma	1.39e-06	3.96e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CCL2—asthma	1.39e-06	3.96e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IL6R—asthma	1.38e-06	3.94e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CCL5—asthma	1.38e-06	3.93e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PLA2G4A—asthma	1.37e-06	3.92e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—LEP—asthma	1.37e-06	3.91e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—CXCL8—asthma	1.37e-06	3.9e-05	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—VEGFA—asthma	1.37e-06	3.9e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—PPP2CA—asthma	1.36e-06	3.88e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CSF2—asthma	1.36e-06	3.87e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—EGFR—asthma	1.36e-06	3.87e-05	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—STAT3—asthma	1.35e-06	3.86e-05	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—IL2—asthma	1.34e-06	3.82e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CCR5—asthma	1.34e-06	3.81e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—SMAD3—asthma	1.32e-06	3.77e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IL2RA—asthma	1.32e-06	3.76e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—FN1—asthma	1.31e-06	3.74e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—IL2—asthma	1.31e-06	3.73e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—C3—asthma	1.31e-06	3.73e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—ALB—asthma	1.3e-06	3.72e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—SERPINE1—asthma	1.3e-06	3.69e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—POMC—asthma	1.29e-06	3.68e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—FN1—asthma	1.29e-06	3.68e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—POMC—asthma	1.28e-06	3.65e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—PDGFB—asthma	1.27e-06	3.63e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—CXCL8—asthma	1.27e-06	3.63e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PPP2CA—asthma	1.27e-06	3.61e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CCL2—asthma	1.26e-06	3.6e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—POMC—asthma	1.26e-06	3.6e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IL6R—asthma	1.26e-06	3.59e-05	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—TGFB1—asthma	1.26e-06	3.58e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CCL2—asthma	1.25e-06	3.57e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—RHOA—asthma	1.25e-06	3.56e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IL6R—asthma	1.25e-06	3.56e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—NOS3—asthma	1.25e-06	3.56e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CCR5—asthma	1.24e-06	3.54e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—EGFR—asthma	1.24e-06	3.53e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CCL2—asthma	1.24e-06	3.53e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—NOS3—asthma	1.24e-06	3.53e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IL6R—asthma	1.23e-06	3.51e-05	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—EGFR—asthma	1.23e-06	3.51e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—EGFR—asthma	1.23e-06	3.49e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IL2RA—asthma	1.23e-06	3.49e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—LEP—asthma	1.22e-06	3.47e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—IL2—asthma	1.22e-06	3.47e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—C3—asthma	1.21e-06	3.46e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—EGFR—asthma	1.21e-06	3.45e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—POMC—asthma	1.2e-06	3.41e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PDGFB—asthma	1.18e-06	3.37e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—SERPINE1—asthma	1.18e-06	3.36e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—POMC—asthma	1.18e-06	3.36e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CCL2—asthma	1.17e-06	3.34e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—SERPINE1—asthma	1.17e-06	3.33e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IL6R—asthma	1.17e-06	3.33e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—POMC—asthma	1.16e-06	3.31e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—SERPINE1—asthma	1.15e-06	3.29e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CCL2—asthma	1.15e-06	3.28e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IL6R—asthma	1.15e-06	3.27e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—FN1—asthma	1.15e-06	3.27e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—EGFR—asthma	1.14e-06	3.26e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—PTGS2—asthma	1.14e-06	3.25e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—RHOA—asthma	1.14e-06	3.25e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—LEP—asthma	1.13e-06	3.22e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—RHOA—asthma	1.13e-06	3.22e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—NOS3—asthma	1.13e-06	3.21e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—EGFR—asthma	1.13e-06	3.21e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—NOS3—asthma	1.12e-06	3.18e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—RHOA—asthma	1.11e-06	3.17e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—NOS3—asthma	1.1e-06	3.14e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CXCL8—asthma	1.1e-06	3.13e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—SERPINE1—asthma	1.09e-06	3.11e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—SERPINE1—asthma	1.08e-06	3.06e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—FN1—asthma	1.07e-06	3.04e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—ALB—asthma	1.06e-06	3.02e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—RHOA—asthma	1.05e-06	3e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IL2—asthma	1.05e-06	2.99e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—POMC—asthma	1.05e-06	2.98e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—IL6—asthma	1.04e-06	2.97e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—NOS3—asthma	1.04e-06	2.97e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—RHOA—asthma	1.04e-06	2.96e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—NOS3—asthma	1.03e-06	2.93e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CCL2—asthma	1.02e-06	2.92e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IL6R—asthma	1.02e-06	2.91e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—NOS3—asthma	1.01e-06	2.89e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—EGFR—asthma	1e-06	2.85e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CXCL8—asthma	1e-06	2.85e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—PTEN—asthma	9.95e-07	2.84e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—MMP9—asthma	9.92e-07	2.83e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CXCL8—asthma	9.9e-07	2.82e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—PTEN—asthma	9.87e-07	2.81e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CXCL8—asthma	9.78e-07	2.79e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—POMC—asthma	9.71e-07	2.77e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IL2—asthma	9.55e-07	2.72e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—SERPINE1—asthma	9.55e-07	2.72e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—IL6—asthma	9.51e-07	2.71e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CCL2—asthma	9.51e-07	2.71e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IL6R—asthma	9.48e-07	2.7e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IL2—asthma	9.47e-07	2.7e-05	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—IL6—asthma	9.46e-07	2.7e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—IL6—asthma	9.42e-07	2.68e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IL2—asthma	9.35e-07	2.66e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—IL6—asthma	9.3e-07	2.65e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—EGFR—asthma	9.3e-07	2.65e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PTGS2—asthma	9.27e-07	2.64e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CXCL8—asthma	9.25e-07	2.64e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—RHOA—asthma	9.21e-07	2.63e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—NOS3—asthma	9.12e-07	2.6e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CXCL8—asthma	9.11e-07	2.6e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—MMP9—asthma	9.04e-07	2.58e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—PTEN—asthma	8.99e-07	2.56e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—MMP9—asthma	8.96e-07	2.55e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—VEGFA—asthma	8.91e-07	2.54e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—PTEN—asthma	8.91e-07	2.54e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—SERPINE1—asthma	8.87e-07	2.53e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—MMP9—asthma	8.84e-07	2.52e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IL2—asthma	8.84e-07	2.52e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—STAT3—asthma	8.82e-07	2.51e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—IL6—asthma	8.8e-07	2.51e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—PTEN—asthma	8.79e-07	2.51e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IL2—asthma	8.7e-07	2.48e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—IL6—asthma	8.66e-07	2.47e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—RHOA—asthma	8.56e-07	2.44e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—NOS3—asthma	8.47e-07	2.41e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—MMP9—asthma	8.37e-07	2.39e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—PTEN—asthma	8.32e-07	2.37e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—MMP9—asthma	8.24e-07	2.35e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—PTEN—asthma	8.19e-07	2.33e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TGFB1—asthma	8.18e-07	2.33e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—VEGFA—asthma	8.12e-07	2.31e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CXCL8—asthma	8.09e-07	2.31e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PTEN—asthma	8.08e-07	2.3e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—VEGFA—asthma	8.04e-07	2.29e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—STAT3—asthma	8.04e-07	2.29e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—EGFR—asthma	8.02e-07	2.29e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—STAT3—asthma	7.97e-07	2.27e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—VEGFA—asthma	7.94e-07	2.26e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—STAT3—asthma	7.86e-07	2.24e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IL2—asthma	7.73e-07	2.2e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—IL6—asthma	7.69e-07	2.19e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CXCL8—asthma	7.51e-07	2.14e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—VEGFA—asthma	7.51e-07	2.14e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TGFB1—asthma	7.45e-07	2.12e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—STAT3—asthma	7.44e-07	2.12e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—VEGFA—asthma	7.4e-07	2.11e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TGFB1—asthma	7.38e-07	2.1e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—STAT3—asthma	7.32e-07	2.09e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—MMP9—asthma	7.32e-07	2.09e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—EGFR—asthma	7.31e-07	2.08e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TGFB1—asthma	7.29e-07	2.08e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—PTEN—asthma	7.27e-07	2.07e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—EGFR—asthma	7.24e-07	2.06e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IL2—asthma	7.18e-07	2.05e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—EGFR—asthma	7.15e-07	2.04e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—IL6—asthma	7.15e-07	2.04e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TGFB1—asthma	6.9e-07	1.97e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—MMP9—asthma	6.8e-07	1.94e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TGFB1—asthma	6.79e-07	1.93e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—EGFR—asthma	6.76e-07	1.93e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PTEN—asthma	6.76e-07	1.93e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—EGFR—asthma	6.66e-07	1.9e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—VEGFA—asthma	6.57e-07	1.87e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—STAT3—asthma	6.5e-07	1.85e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IL6—asthma	6.16e-07	1.76e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—VEGFA—asthma	6.1e-07	1.74e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—STAT3—asthma	6.04e-07	1.72e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TGFB1—asthma	6.03e-07	1.72e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—EGFR—asthma	5.91e-07	1.69e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IL6—asthma	5.62e-07	1.6e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TGFB1—asthma	5.6e-07	1.6e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IL6—asthma	5.56e-07	1.59e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IL6—asthma	5.49e-07	1.57e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—EGFR—asthma	5.49e-07	1.57e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IL6—asthma	5.2e-07	1.48e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IL6—asthma	5.11e-07	1.46e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IL6—asthma	4.54e-07	1.3e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IL6—asthma	4.22e-07	1.2e-05	CbGpPWpGaD
